A case of pulmonary aspergillosis with lack of response to caspofungin

Revista Iberoamericana de Micologia

Volumn 23, Issue 2, 2006, Pages 94-95

  Rüchel, Reinhard ^a,b   Perske, Christine ^a   Glaß, Bertram ^a   Bäsecke, Jörg ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Institute of Hygiene   (Germany)

Author keywords

Antifungal; Aspergillus fumigatus; Caspofungin; Invasive aspergillosis; Resistance; Treatment

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CORTISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRIAZOLE; VORICONAZOLE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LABORATORY TEST; LEUKEMIA; LUNG ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; PHYSICAL EXAMINATION; RESPIRATORY FAILURE; SEROLOGY; TREATMENT FAILURE;

ASPERGILLUS;

EID: 33746481522     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(06)70021-3     Document Type: Article

References (9)

1. Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N. Efficacy of caspofungin against invasive Candida or Aspergillus infections in neutropenic patients. Cancer 2006; 106: 466-473.
2. Böhme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel GP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Südhoff T, Szelenyi H, Ullmann AJ. Treatment of fungal infections in haematology and oncology. Ann Hematol 2003; 82 (Suppl. 2): S133-S140.
3. Espinel-Ingroff A. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate. J Clin Microbiol 2003; 41: 403-409.
4. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39: 1563-1571.
5. Marr KA, Balajee SA, McLaughlin L, Taboured M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-649.
6. Nakai T, Hatano K, Ikeda F, Shibuya K. Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice. Med Mycol 2005; 43: 439-445.
7. Odds FC, Motyl M, Andrade R, Bille J, Canton E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdière M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Pemán J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JR, Rinaldi MG, Rodriguez-Tudela JL, Schell WA, Shields C, Sutton DA, Verweij PE, Warnock DW. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol 2004; 42: 3475-3482.
8. Rüchel R, Dellmann A, Schaffrinski K, Donhuijsen K. Vereinfachte Pilzdetektion: Screeningmethode mit optischem Aufheller. Pathologe 2004; 25: 235-237.
9. Wulf GG, Conradi I, Rüchel R. Diagnostische Wertigkeit des Nachweises von Antikörpern gegen Candida-Keimschlauchantigene bei einer Patientin mit hepatolienaler Candidose. Mycoses 2004; 47 (Suppl. 1): 11-14.